These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 8540693)
1. SB 205952, a novel semisynthetic monic acid analog with at least two modes of action. Wilson JM; Oliva B; Cassels R; O'Hanlon PJ; Chopra I Antimicrob Agents Chemother; 1995 Sep; 39(9):1925-33. PubMed ID: 8540693 [TBL] [Abstract][Full Text] [Related]
2. The chemistry of pseudomonic acid. 17. Dual-action C-1 oxazole derivatives of pseudomonic acid having an extended spectrum of antibacterial activity. Broom NJ; Cassels R; Cheng HY; Elder JS; Hannan PC; Masson N; O'Hanlon PJ; Pope A; Wilson JM J Med Chem; 1996 Aug; 39(18):3596-600. PubMed ID: 8784459 [TBL] [Abstract][Full Text] [Related]
3. Mupirocin resistance in staphylococci: development and transfer of isoleucyl-tRNA synthetase-mediated resistance in vitro. Thomas DG; Wilson JM; Day MJ; Russell AD J Appl Microbiol; 1999 Apr; 86(4):715-22. PubMed ID: 10212417 [TBL] [Abstract][Full Text] [Related]
4. High-level mupirocin resistance in Staphylococcus aureus: evidence for two distinct isoleucyl-tRNA synthetases. Gilbart J; Perry CR; Slocombe B Antimicrob Agents Chemother; 1993 Jan; 37(1):32-8. PubMed ID: 8431015 [TBL] [Abstract][Full Text] [Related]
5. Mechanism of mupirocin transport into sensitive and resistant bacteria. Capobianco JO; Doran CC; Goldman RC Antimicrob Agents Chemother; 1989 Feb; 33(2):156-63. PubMed ID: 2497702 [TBL] [Abstract][Full Text] [Related]
6. Analysis of mupirocin resistance and fitness in Staphylococcus aureus by molecular genetic and structural modeling techniques. Hurdle JG; O'Neill AJ; Ingham E; Fishwick C; Chopra I Antimicrob Agents Chemother; 2004 Nov; 48(11):4366-76. PubMed ID: 15504866 [TBL] [Abstract][Full Text] [Related]
7. Antimicrobial properties and mode of action of the pyrrothine holomycin. Oliva B; O'Neill A; Wilson JM; O'Hanlon PJ; Chopra I Antimicrob Agents Chemother; 2001 Feb; 45(2):532-9. PubMed ID: 11158751 [TBL] [Abstract][Full Text] [Related]
8. Global analysis of the Staphylococcus aureus response to mupirocin. Reiss S; Pané-Farré J; Fuchs S; François P; Liebeke M; Schrenzel J; Lindequist U; Lalk M; Wolz C; Hecker M; Engelmann S Antimicrob Agents Chemother; 2012 Feb; 56(2):787-804. PubMed ID: 22106209 [TBL] [Abstract][Full Text] [Related]
9. New quadriplex PCR assay for detection of methicillin and mupirocin resistance and simultaneous discrimination of Staphylococcus aureus from coagulase-negative staphylococci. Zhang K; Sparling J; Chow BL; Elsayed S; Hussain Z; Church DL; Gregson DB; Louie T; Conly JM J Clin Microbiol; 2004 Nov; 42(11):4947-55. PubMed ID: 15528678 [TBL] [Abstract][Full Text] [Related]
10. Mupirocin resistance screening of methicillin-resistant Staphylococcus aureus isolates at Madigan Army Medical Center. Perkins D; Hogue JS; Fairchok M; Braun L; Viscount HB Mil Med; 2008 Jun; 173(6):604-8. PubMed ID: 18595427 [TBL] [Abstract][Full Text] [Related]
11. Prevalence and mechanisms of low- and high-level mupirocin resistance in staphylococci isolated from a Korean hospital. Yun HJ; Lee SW; Yoon GM; Kim SY; Choi S; Lee YS; Choi EC; Kim S J Antimicrob Chemother; 2003 Mar; 51(3):619-23. PubMed ID: 12615863 [TBL] [Abstract][Full Text] [Related]
13. Use of the polymerase chain reaction for rapid detection of high-level mupirocin resistance in staphylococci. Anthony RM; Connor AM; Power EG; French GL Eur J Clin Microbiol Infect Dis; 1999 Jan; 18(1):30-4. PubMed ID: 10192711 [TBL] [Abstract][Full Text] [Related]
14. Biochemical basis of mupirocin resistance in strains of Staphylococcus aureus. Farmer TH; Gilbart J; Elson SW J Antimicrob Chemother; 1992 Nov; 30(5):587-96. PubMed ID: 1493977 [TBL] [Abstract][Full Text] [Related]
15. The isoleucyl-tRNA synthetase mutation V588F conferring mupirocin resistance in glycopeptide-intermediate Staphylococcus aureus is not associated with a significant fitness burden. Hurdle JG; O'Neill AJ; Chopra I J Antimicrob Chemother; 2004 Jan; 53(1):102-4. PubMed ID: 14657089 [TBL] [Abstract][Full Text] [Related]
16. Emerging elevated mupirocin resistance rates among staphylococcal isolates in the SENTRY Antimicrobial Surveillance Program (2000): correlations of results from disk diffusion, Etest and reference dilution methods. Deshpande LM; Fix AM; Pfaller MA; Jones RN; Diagn Microbiol Infect Dis; 2002 Apr; 42(4):283-90. PubMed ID: 12007448 [TBL] [Abstract][Full Text] [Related]
17. Isoleucyl-tRNA synthetase mutations in Staphylococcus aureus clinical isolates and in vitro selection of low-level mupirocin-resistant strains. Fujimura S; Tokue Y; Watanabe A Antimicrob Agents Chemother; 2003 Oct; 47(10):3373-4. PubMed ID: 14506063 [No Abstract] [Full Text] [Related]
18. [Bactericidal action of lomefloxacin a new pyridonecarboxylic acid derivative]. Koikeda S; Okabe H; Shibata H; Hase T; Nakanishi N; Okezaki E; Kato H; Masamune Y Jpn J Antibiot; 1989 Jan; 42(1):193-9. PubMed ID: 2468799 [TBL] [Abstract][Full Text] [Related]
19. Cloning of the gene conferring resistance to mupirocin in Staphylococcus aureus. Dyke KG; Curnock SP; Golding M; Noble WC FEMS Microbiol Lett; 1991 Jan; 61(2-3):195-8. PubMed ID: 1903747 [TBL] [Abstract][Full Text] [Related]
20. Mechanism of action of DuP 721: inhibition of an early event during initiation of protein synthesis. Eustice DC; Feldman PA; Zajac I; Slee AM Antimicrob Agents Chemother; 1988 Aug; 32(8):1218-22. PubMed ID: 2461163 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]